CIK 0001601830
- Large accelerated filer
RECURSION PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- RXRX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 464099738
- Phone
- +1 385-269-0203
- Business address
- 41S RIO GRANDE STREET, SALT LAKE CITY, UT, 84101
- Former names
- Recursion Pharmaceuticals, LLC
- 4 Grant or award Director acquired 2,941 shares (grant or award)
- 4 Planned sale Chief Executive Officer sold 100,000 shares at $4.76 ($476,000)
- 4 Shares withheld for taxes Chief Financial Officer gave up 7,057 shares (to pay taxes)
- 4 Planned sale Chief Executive Officer sold 100,000 shares at $4.71 ($471,000)
- 4 Planned sale Chief Executive Officer sold 100,000 shares at $4.84 ($484,000)
- 4 Shares withheld for taxes Chief Financial Officer gave up 11,908 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Executive Officer gave up 40,390 shares (to pay taxes)
- 4 Open-market sale Chief R&D Commercial Officer sold 36,599 shares at $5.52 ($202,173)
- 4 Planned sale Chief Executive Officer sold 618,175 shares at $5.28 ($3,263,964)
- 4 Grant or award Director acquired 1,949 shares (grant or award)
- 4 Grant or award Director acquired 2,924 shares (grant or award)
- 4 Grant or award Director acquired 22,016 shares (grant or award)
- 4 Grant or award Director acquired 22,016 shares (grant or award)
- 4 Grant or award Director acquired 22,016 shares (grant or award)
- 4 Grant or award Director acquired 22,016 shares (grant or award)
- 4 Grant or award Director acquired 11,008 shares (grant or award)
- 4 Grant or award Director acquired 22,016 shares (grant or award)
- 4 Grant or award Director acquired 11,008 shares (grant or award)
- 4 Shares withheld for taxes Chief Financial Officer gave up 7,057 shares (to pay taxes)
- 4 Shares withheld for taxes Chief R&D Commercial Officer gave up 3,796 shares (to pay taxes)
Page 5 of 26 · 512 filings